(FM) Neurología

2025

1. A Call for Change: Updating the Operational Definition for Dementia in Parkinson's Disease

   Movement Disorders Clinical Practice, Vol. 12, Núm. 3, pp. 296-301

2. Bilateral Lesions in Parkinson's Disease: Gaps and Controversies

   Movement Disorders, Vol. 40, Núm. 2, pp. 231-240

3. Bridging the gap between aberrant time processing and cognitive dysfunction in schizophrenia: a potential core feature?

   Schizophrenia, Vol. 11, Núm. 1, pp. 31

4. Cerebrovascular Reactivity Mapping in Brain Tumors Based on a Breath-Hold Task Using Arterial Spin Labeling

   NMR in Biomedicine, Vol. 38, Núm. 3

5. Comparison of two automated immunoassays for quantifying ProGRP, SCC and HE4 in serum: impact on diagnostic accuracy

   Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 85, Núm. 2, pp. 116-124

6. Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group

   Neurologia, Vol. 40, Núm. 1, pp. 118-137

7. Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders

   Journal of Clinical Immunology, Vol. 45, Núm. 1

8. FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease

   Molecular Therapy, Vol. 33, Núm. 3, pp. 895-916

9. Ibero-American consensus statement on migraine treatment

   Neurology Perspectives, Vol. 5, Núm. 1

10. Standardizing the large-volume “tap test” for evaluating idiopathic normal pressure hydrocephalus: a systematic review

    Journal of Neurosurgical Sciences, Vol. 69, Núm. 1, pp. 46-63

11. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut, Vol. 74, Núm. 2, pp. 270-283